CVS Health Corporation
CVS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $95,670 | $87,329 | $85,433 | $56,517 |
| - Cash | $9,155 | $11,787 | $10,076 | $8,586 |
| + Debt | $81,752 | $82,724 | $81,213 | $82,920 |
| Enterprise Value | $168,267 | $158,266 | $156,570 | $130,851 |
| Revenue | $102,871 | $98,915 | $94,588 | $97,710 |
| % Growth | 4% | 4.6% | -3.2% | – |
| Gross Profit | $13,806 | $13,593 | $14,396 | $12,899 |
| % Margin | 13.4% | 13.7% | 15.2% | 13.2% |
| EBITDA | -$1,564 | $3,581 | $4,556 | $4,027 |
| % Margin | -1.5% | 3.6% | 4.8% | 4.1% |
| Net Income | -$3,975 | $1,021 | $1,779 | $1,644 |
| % Margin | -3.9% | 1% | 1.9% | 1.7% |
| EPS Diluted | -3.13 | 0.8 | 1.41 | 1.3 |
| % Growth | -491.3% | -43.3% | 8.5% | – |
| Operating Cash Flow | $796 | $1,897 | $4,556 | $1,860 |
| Capital Expenditures | -$698 | -$607 | -$743 | -$768 |
| Free Cash Flow | $98 | $1,290 | $3,813 | $1,092 |